(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...
MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026: New York Monday, April 6 ...
ABION, a precision oncology therapeutics developer, announced its next-generation immuno-oncology candidate ABN202 will be ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion ...
A new single‑cell method, CIPHER‑seq, measures RNA and proteins together to reveal real‑time cytokine signaling.
(Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster ...
Cancer biology research increasingly recognizes the profound heterogeneity and plasticity of cancer cells. These cells can transition dynamically between ...
The intestinal immune system plays a pivotal role in maintaining mucosal homeostasis, acting as the interface between environmental stimuli, host epithelial ...
Officials in Minnesota have sued the Trump administration, saying federal officials are withholding evidence in the killings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results